STRS Ohio’s Perspective Therapeutics CATX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-5,300
Closed -$22.1K 2182
2026
Q1
$22.1K Hold
5,300
﹤0.01% 2046
2025
Q4
$14.6K Hold
5,300
﹤0.01% 2120
2025
Q3
$18.2K Hold
5,300
﹤0.01% 2122
2025
Q2
$18.2K Hold
5,300
﹤0.01% 2140
2025
Q1
$11.3K Hold
5,300
﹤0.01% 1877
2024
Q4
$16.9K Hold
5,300
﹤0.01% 1822
2024
Q3
$70.8K Sell
5,300
-3,400
-39% -$45.2K ﹤0.01% 1760
2024
Q2
$86.7K Buy
+8,700
New +$126K ﹤0.01% 1721

Other funds holding CATX

STRS Ohio's CATX Position: Q2 2026 in Review

STRS Ohio sold out of Perspective Therapeutics (CATX) in Q2 2026, closing a stake of 5,300 shares — an estimated $22.1K sold.

STRS Ohio first reported a position in CATX in Q2 2024 and held it in 8 quarters. The position peaked at $86.7K in Q2 2024. 132 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • STRS Ohio reported no remaining Perspective Therapeutics position as of Q2 2026 after selling out during the quarter.
  • STRS Ohio sold 5,300 Perspective Therapeutics shares in Q2 2026, an estimated $22.1K.
  • STRS Ohio first reported a position in Perspective Therapeutics in Q2 2024 and held it in 8 quarters.
  • STRS Ohio's Perspective Therapeutics position peaked at $86.7K in Q2 2024.
  • 132 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.